Shares of AdaptHealth Corp. (NASDAQ:AHCO – Get Free Report) have earned an average recommendation of “Moderate Buy” from the nine research firms that are presently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and seven have given a buy recommendation to the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is $14.1429.
A number of equities analysts have recently commented on AHCO shares. Royal Bank Of Canada lifted their price target on shares of AdaptHealth from $13.00 to $15.00 and gave the company an “outperform” rating in a research report on Monday, May 11th. Canaccord Genuity Group upped their price objective on shares of AdaptHealth from $14.00 to $16.00 and gave the stock a “buy” rating in a report on Wednesday, May 6th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of AdaptHealth in a report on Friday, May 22nd. Jefferies Financial Group upgraded shares of AdaptHealth from a “hold” rating to a “buy” rating and raised their target price for the company from $11.00 to $13.00 in a research note on Tuesday, July 21st. Finally, Truist Financial lifted their target price on shares of AdaptHealth from $13.00 to $14.00 and gave the stock a “buy” rating in a report on Monday, April 13th.
Get Our Latest Report on AdaptHealth
AdaptHealth Stock Up 1.1%
Insider Transactions at AdaptHealth
In other news, insider Russell E. Schuster III sold 11,275 shares of the firm’s stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $10.06, for a total value of $113,426.50. Following the sale, the insider directly owned 136,538 shares of the company’s stock, valued at approximately $1,373,572.28. This trade represents a 7.63% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.95% of the stock is owned by company insiders.
Hedge Funds Weigh In On AdaptHealth
Institutional investors have recently made changes to their positions in the business. Rockefeller Capital Management L.P. boosted its stake in AdaptHealth by 433.0% during the 4th quarter. Rockefeller Capital Management L.P. now owns 2,585 shares of the company’s stock valued at $26,000 after purchasing an additional 2,100 shares during the period. Assetmark Inc. increased its position in AdaptHealth by 54.8% in the 1st quarter. Assetmark Inc. now owns 6,952 shares of the company’s stock worth $83,000 after buying an additional 2,460 shares during the period. PNC Financial Services Group Inc. lifted its holdings in shares of AdaptHealth by 22.3% during the fourth quarter. PNC Financial Services Group Inc. now owns 7,003 shares of the company’s stock worth $70,000 after buying an additional 1,279 shares during the last quarter. Tower Research Capital LLC TRC lifted its holdings in shares of AdaptHealth by 318.0% during the second quarter. Tower Research Capital LLC TRC now owns 9,592 shares of the company’s stock worth $90,000 after buying an additional 7,297 shares during the last quarter. Finally, Sanctuary Advisors LLC bought a new stake in shares of AdaptHealth in the first quarter valued at approximately $120,000. 82.67% of the stock is currently owned by institutional investors.
About AdaptHealth
AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.
The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.
Featured Stories
- Five stocks we like better than AdaptHealth
- Chevron’s Strong Quarter Shows Why It Still Leads the Energy Sector
- Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
- Apple’s Record Quarter Could Not Outrun Its Guidance Problem
- McKesson’s Compounding Keeps Adding Up
Receive News & Ratings for AdaptHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdaptHealth and related companies with MarketBeat.com's FREE daily email newsletter.
-etf-logo-1200x675.png){kind=logo}
